Biotech Catches Major Premarket Bid Following Financial Results - MSN

BPTSDelisted Stock  USD 7.03  0.00  0.00%   
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
  
Biotech Catches Major Premarket Bid Following Financial Results MSN

Read at news.google.com
Google News at Macroaxis
  

Biophytis Fundamental Analysis

We analyze Biophytis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Biophytis is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Biophytis Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biophytis stock to make a market-neutral strategy. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics with similar companies.

Peers

Biophytis Related Equities

NRXPNRX Pharmaceuticals   0.84   
0%
4.0%
ANEBAnebulo Pharmaceuticals   0.72   
0%
3.0%
XOMAOXOMA   0.51   
0%
2.0%
AKTXAkari Therapeutics   0.31   
0%
1.0%
RZLTRezolute   0.22   
0%
1.0%
CHRSCoherus BioSciences   0.00   
0%
0%
ARMPArmata Pharmaceuticals   0.00   
0%
0%
BOLTBolt Biotherapeutics   0.38   
2.0%
0%
HCWBHCW Biologics   0.83   
4.0%
0%
INBXInhibrx   0.88   
4.0%
0%
TPSTTempest Therapeutics   0.93   
5.0%
0%
PTIXProtagenic Therapeutics   1.00   
5.0%
0%
SPROSpero Therapeutics   2.73   
14.0%
0%
PCSAProcessa Pharmaceuticals   6.31   
34.0%
0%
IPHAInnate Pharma   18.54   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Biophytis Stock

If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device